Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
about
The intracellular domain of ErbB4 induces differentiation of mammary epithelial cellsEvidence for regulation of the tumor necrosis factor alpha-convertase (TACE) by protein-tyrosine phosphatase PTPH1Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE)The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperoneThe transferrin receptor-1 membrane stub undergoes intramembrane proteolysis by signal peptide peptidase-like 2bInteraction of nectin-like molecule 2 with integrin alpha6beta4 and inhibition of disassembly of integrin alpha6beta4 from hemidesmosomesEngineering N-terminal domain of tissue inhibitor of metalloproteinase (TIMP)-3 to be a better inhibitor against tumour necrosis factor-alpha-converting enzymeMechanisms of neuregulin actionA Disintegrin and Metalloprotease (ADAM): Historical Overview of Their FunctionsReceptor tyrosine kinases in the nucleusProtease regulation: the Yin and Yang of neural development and diseaseProteolytic Processing of ErbB4 in Breast CancerNuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer.Catalytic properties of ADAM19Roles of the juxtamembrane and extracellular domains of angiotensin-converting enzyme in ectodomain sheddingHey2 regulation by FGF provides a Notch-independent mechanism for maintaining pillar cell fate in the organ of CortiThe E3 ubiquitin ligase WWP1 selectively targets HER4 and its proteolytically derived signaling isoforms for degradationErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migrationThe novel mouse mutant, chuzhoi, has disruption of Ptk7 protein and exhibits defects in neural tube, heart and lung development and abnormal planar cell polarity in the ear.Cell death or survival promoted by alternative isoforms of ErbB4Insulin-response element-binding protein 1: a novel Akt substrate involved in transcriptional action of insulin.Removal of cell surface heparan sulfate increases TACE activity and cleavage of ErbB4 receptor.ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanismsThe carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulationThe interaction of the ErbB4 intracellular domain p80 with α-enolase in the nuclei is associated with the inhibition of the neuregulin1-dependent cell proliferation.ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1)Characterization of protein tyrosine phosphatase H1 knockout mice in animal models of local and systemic inflammationThe HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation.Signaling of ERBB receptor tyrosine kinases promotes neuroblastoma growth in vitro and in vivoIntracellular processing of metalloprotease disintegrin ADAM12.The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits.Modulation of CD163 expression by metalloprotease ADAM17 regulates porcine reproductive and respiratory syndrome virus entryPhorbol 12-myristate 13-acetate-induced release of the colony-stimulating factor 1 receptor cytoplasmic domain into the cytosol involves two separate cleavage eventsTransmodulation of cell surface regulatory molecules via ectodomain shedding.Presenilin-1 processing of ErbB4 in fetal type II cells is necessary for control of fetal lung maturation.Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancerMolecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility geneDecorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissueRegulated intramembrane proteolysis and degradation of murine epithelial cell adhesion molecule mEpCAM.HER4 in breast cancer: comparison of antibodies against intra- and extra-cellular domains of HER4
P2860
Q24296970-A13096F7-596E-447E-903D-1CDF18EE7C9FQ24305944-753295A6-F5B8-4C7C-9EFE-2021A702F220Q24306455-C8B24FC8-1508-47A1-9670-A64C661CA900Q24313108-28750D0D-A780-4764-8586-369ACF8D0824Q24314475-E265E373-CA9C-4D79-B230-2358DFD9DD40Q24336974-C362F055-BB09-4229-9A8A-63992134C6A8Q24534110-1768659B-4777-4873-9A77-9B7CDEA1F0C8Q24650665-80FE95A6-DFAC-410D-BD66-7E0AC0C4C2D1Q26749364-607D66CA-8C75-4AAE-AAE6-71D79101C173Q26830216-57583600-0260-411B-8AAC-52B848C9FDBCQ27000161-8E7943FC-5295-43ED-9ADF-B02C47A9DD83Q27670640-932D0C67-E73A-4B54-A590-F4CC34503881Q27853060-47F6584E-8C76-4325-9F60-75FA0E4F425EQ28189426-601163BB-E742-4BD0-A240-E465F5527240Q28345230-D7986F4C-784E-46C5-8A70-227D0AC7D3B5Q28507372-D991E95F-0D65-4183-BA8B-1C9A5D1CE2CCQ28511737-BC26B9F4-D2CA-4734-9C3C-5C70E9E49E3AQ28578116-ED965CF6-A171-4CDB-8C4D-298415390EF9Q28585297-54AC0520-AC7C-4139-AA1F-733300639E51Q28593348-EDC210D8-5B54-4CC4-9FF0-415A43F83614Q33203721-9B47F92F-D312-4BD9-95BB-2E5CC211323FQ33403045-9931594A-48DE-4E89-8D1E-D41EBFDF89CFQ33574071-DBF1A018-8C9D-42C2-AB2E-CFF98917AA34Q33734632-209D23DD-2D10-4255-A57B-971523A1DEC6Q33760474-1EAEA16E-EF5B-4217-AE37-08F0FDD1BC2CQ33772914-31F407DD-DB97-470E-8A7D-BAE3BC128883Q33864417-8EDA5D1A-AE2E-48AF-8C3A-D37DF47857B1Q34048265-6843C989-B6F3-4FE8-9466-FC3A901785ADQ34072567-E250A6E0-EB46-4D85-A921-8DD6BD87EB84Q34127626-FE084061-8712-4F9A-9136-F5D62D3D53B4Q34217470-712DFE9D-06E3-4D66-ACF0-442C5E431C37Q34262328-8880A148-BBC4-435A-9FF2-03E06C0212E1Q34551375-D28603C7-8EA5-493B-A98B-8DDE2E11F96AQ34584816-A75A2B22-9F38-4E8E-9419-C386081FDD3EQ34612339-E4C3347D-11B3-4D38-B470-A883EE6F0164Q34613588-BB49A68D-C1D6-476B-97B6-98F84D5C7F47Q34639446-07A757A3-9658-48B1-BB7A-0D1E41EC992DQ34754640-6991E7EA-291A-4687-8C16-A6F65C817E89Q34979489-EF5BAB79-BE45-499D-9BAE-312F4370DF7AQ35012797-349E3BFA-069F-42A5-96C2-4B140B4CC13D
P2860
Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
description
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2000
@ast
im April 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/04/07)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/04/07)
@nl
наукова стаття, опублікована у квітні 2000
@uk
name
Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
@ast
Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
@en
Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
@nl
type
label
Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
@ast
Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
@en
Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
@nl
prefLabel
Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
@ast
Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
@en
Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
@nl
P2093
P2860
P3181
P356
P1476
Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4
@en
P2093
J. D. Buxbaum
J. J. Peschon
P2860
P304
10379–10387
P3181
P356
10.1074/JBC.275.14.10379
P407
P577
2000-04-07T00:00:00Z